SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
SOLESENCE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.89−0.01 (-0.81%)
Close on Oct 19, 2026
- Market cap
- $63.06M
- P/E (TTM)
- –
- Dividend yield
- –
SOLESENCE, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $61.79M | $51.89M | $1.66M | $1.24M | $2.34M | $3.45M | $11.85M | $14.04M | $12.13M | – | 99.6% | +19.1% |
| Consumer Products [Member] | $54.87M | $44.37M | $25.21M | – | – | – | – | – | – | – | 88.4% | +23.7% |
| Personal Care ingredients [Member] | $6.34M | $6.83M | $9.28M | $11.12M | $7.74M | $6.74M | – | – | – | – | 10.2% | -7.1% |
| Advanced Materials [Member] | $857.00K | $1.15M | $2.81M | $3.09M | $3.56M | $5.54M | $2.73M | $2.25M | $4.54M | – | 1.4% | -25.3% |
| Product and Service, Other [Member] | $270.00K | $457.00K | $656.00K | $586.00K | $150.00K | $701.00K | $657.00K | $153.00K | $342.00K | – | 0.4% | -40.9% |
| Solesence [Member] | – | – | $25.21M | $23.11M | $18.18M | $4.85M | $1.86M | $1.37M | $54.00K | – | – | – |
| Technology Development Fee [Member] | – | – | – | – | – | – | $211.00K | $20.00K | $250.00K | – | – | – |
| Personal Care Ingredients [Member] | – | – | – | – | – | $5.54M | $7.92M | $10.57M | – | – | – | – |
| Technology Development Fee [Member] | – | – | – | – | – | – | $289.00K | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-US [Member] | $5.17M | $1.83M | $2.92M | $1.97M | $3.24M | $3.71M | $1.20M | $600.00K | $1.84M | $1.04M | 8.3% | +183.2% |
| Germany [Member] | – | – | – | – | – | – | – | – | – | $902.00K | – | – |
| Germany | – | – | – | – | – | $3.45M | $1.10M | $534.00K | $1.71M | $902.00K | – | – |
From the segment and revenue-disaggregation notes of Solesence's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.